WFDC2 and pancreatic neoplasm: Furthermore, our previous research demonstrated that elevated WFDC2 expression in pancreatic cancer is associated with increased tumor aggressiveness and chemotherapy resistance (15), with overexpression correlating with significantly shorter OS.